Stats
Alexa Rank: 9115034
Popular in Country:
Country Alexa Rank:
language:
Response Time:
SSL: Disable
Status: up
Code To Txt Ratio
Word Count
Links
ratio
Found 22 Top Alternative to Hcpfirst.com
Entresto.com
Learn About ENTRESTO® (sacubitril/valsartan)
What is the most important information I should know about ENTRESTO? ENTRESTO can harm or cause death to your unborn baby. Talk to your doctor about other ways to treat heart failure if you plan to become pregnant. If you get pregnant during treatment with ENTRESTO, tell your doctor right...
45.60.129.251
United States
Valid SSL
Entrestohcp.com
ENTRESTO® (sacubitril/valsartan) | HCP Website
INDICATION ENTRESTO is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection fraction (LVEF) below normal. LVEF is a variable measure, so use clinical judgment in deciding whom...
Cosentyxhcp.com
Dermatology & Rheumatology Resources | COSENTYX® (secukinumab) | HCP
Access resources for both dermatologists and rheumatologists to learn more about COSENTYX, a biologic injection. See full Prescribing & Safety Info.
Novartispharma.com
Stories | Novartis
Explore stories about how Novartis innovation has impacted people worldwide.
Patientassistancenow.com
Patient Assistance | Novartis United States of America
Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to afford their medicines.
Cosentyx.com
COSENTYX® (secukinumab)
Learn more about COSENTYX (secukinumab), a prescription medication for treating moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
Novartis.us
Novartis United States of America
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Focalinxr.com
FOCALINXR® (dexmethylphenidate hydrochloride)
IMPORTANT SAFETY INFORMATION IMPORTANT SAFETY INFORMATION AND INDICATION What is the most important information I should know about FOCALIN XR? FOCALIN XR is a federal controlled substance (CII) because it can be abused or lead to dependence. Keep FOCALIN XR in a safe place to prevent misuse and abuse. Selling...
Technologies Used by hcpfirst.com
Dns Records of hcpfirst.com
A Record: 164.109.71.153AAAA Record:
CNAME Record:
NS Record: a7-64.akam.net dns1.novartis.com a9-65.akam.net dns3.novartis.com dns2.novartis.com a1-254.akam.net a28-67.akam.net a2-66.akam.net a24-65.akam.net dns4.novartis.com
SOA Record: hostmaster.novartis.com
MX Record:
SRV Record:
TXT Record: 05320c6b-2fc0-4586-b91c-0157c4902a27 QuoVadis=f50c1140-67d3-421e-a442-56eceb12e8cf
DNSKEY Record:
CAA Record:
Whois Detail of hcpfirst.com
Domain Name: hcpfirst.comRegistry Domain ID: 1940441895_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2022-06-17T07:11:27+0000
Creation Date: 2015-06-20T14:12:22+0000
Registrar Registration Expiration Date: 2023-06-20T07:00:00+0000
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.2083895770
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID:
Registrant Name: Domain Admin
Registrant Organization: Novartis AG
Registrant Street: P.O. Box CH-4002,
Registrant City: Basel
Registrant State/Province: CH
Registrant Postal Code: 4002
Registrant Country: CH
Registrant Phone: +1.2083895740
Registrant Phone Ext:
Registrant Fax: +1.2083895799
Registrant Fax Ext:
Registrant Email: [email protected]
Admin Organization: MarkMonitor, Inc.
Admin State/Province: ID
Admin Country: US
Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/hcpfirst.com
Tech Organization: MarkMonitor, Inc.
Tech State/Province: ID
Tech Country: US
Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/hcpfirst.com
Name Server: dns1.novartis.com
Name Server: a24-65.akam.net
Name Server: dns3.novartis.com
Name Server: a1-254.akam.net
Name Server: a7-64.akam.net
Name Server: dns2.novartis.com
Name Server: a9-65.akam.net
Name Server: dns4.novartis.com
Name Server: a28-67.akam.net
Name Server: a2-66.akam.net
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2022-06-17T07:47:33+0000 <<<
For more information on WHOIS status codes, please visit:
https://www.icann.org/resources/pages/epp-status-codes
If you wish to contact this domain’s Registrant, Administrative, or Technical
contact, and such email address is not visible above, you may do so via our web
form, pursuant to ICANN’s Temporary Specification. To verify that you are not a
robot, please enter your email address to receive a link to a page that
facilitates email communication with the relevant contact(s).
Web-based WHOIS:
https://domains.markmonitor.com/whois
If you have a legitimate interest in viewing the non-public WHOIS details, send
your request and the reasons for your request to [email protected]
and specify the domain name in the subject line. We will review that request and
may ask for supporting documentation and explanation.
The data in MarkMonitor’s WHOIS database is provided for information purposes,
and to assist persons in obtaining information about or related to a domain
name’s registration record. While MarkMonitor believes the data to be accurate,
the data is provided "as is" with no guarantee or warranties regarding its
accuracy.
By submitting a WHOIS query, you agree that you will use this data only for
lawful purposes and that, under no circumstances will you use this data to:
(1) allow, enable, or otherwise support the transmission by email, telephone,
or facsimile of mass, unsolicited, commercial advertising, or spam; or
(2) enable high volume, automated, or electronic processes that send queries,
data, or email to MarkMonitor (or its systems) or the domain name contacts (or
its systems).
MarkMonitor reserves the right to modify these terms at any time.
By submitting this query, you agree to abide by this policy.
MarkMonitor Domain Management(TM)
Protecting companies and consumers in a digital world.
Visit MarkMonitor at https://www.markmonitor.com
Contact us at +1.8007459229
In Europe, at +44.02032062220
----